<p>Vest Financial LLC 在最近向美國證券交易委員會提交的 13F 表格中表示，其在 Elevance Health, Inc. (NYSE:ELV - 免費報告) 的持股在第三季度減少了 10.8%。該基金在此期間出售了 10,817 股後，持有該公司 88,982 股股票。Vest Financial LLC 在 Elevance Health 的持股在最近的報告期末價值為 28,752,000 美元。</p>
<ul>
<li>這個 ETF 證明了醫療保健反彈是真實的</li>
</ul>
<p>其他幾家對沖基金和機構投資者最近也買賣了該公司的股票。Joel Isaacson &amp; Co. LLC 在第三季度將其在 Elevance Health 的股份增加了 45.3%。Joel Isaacson &amp; Co. LLC 現在擁有 1,765 股該公司的股票，價值 570,000 美元，此前在上個季度又購買了 550 股。Sage Mountain Advisors LLC 在第三季度將其在 Elevance Health 的持股增加了 18.2%。Sage Mountain Advisors LLC 現在擁有 1,848 股該公司的股票，價值 597,000 美元，此前在上個季度又收購了 285 股。Jackson Thornton Wealth Management LLC 在第三季度購買了 Elevance Health 的新頭寸，價值 256,000 美元。Americana Partners LLC 在第三季度獲得了 Elevance Health 的新頭寸，價值 393,000 美元。最後，Professional Advisory Services Inc. 在第三季度將其在 Elevance Health 的股份增加了 1.6%。Professional Advisory Services Inc. 現在擁有 76,354 股該公司的股票，價值 24,672,000 美元，此前在上個季度又購買了 1,170 股。目前，89.24% 的股票由對沖基金和其他機構投資者持有。</p>
<p>獲取 <strong>Elevance Health</strong> 的提醒：</p>
<h2>華爾街分析師預測增長</h2>
<p>幾位股票分析師最近對該股票發表了評論。Sanford C. Bernstein 在 1 月 6 日的研究報告中重申了 “跑贏大盤” 的評級，並設定了 Elevance Health 股票的目標價為 431.00 美元。Robert W. Baird 將 Elevance Health 的目標價從 297.00 美元上調至 340.00 美元，並在 12 月 11 日的報告中給予該股票 “中性” 評級。Mizuho 在 1 月 9 日的報告中設定了 Elevance Health 的目標價為 413.00 美元。美國銀行在 10 月 10 日的研究報告中將 Elevance Health 的目標價從 330.00 美元上調至 370.00 美元，並給予該公司 “中性” 評級。最後，富國銀行在 1 月 7 日的報告中將 Elevance Health 股票的目標價從 403.00 美元上調至 424.00 美元，並給予該股票 “超配” 評級。十三位分析師對該股票給予了買入評級，十二位分析師對該公司的股票給予了持有評級。根據 MarketBeat 的數據，該公司目前的平均評級為 “適度買入”，平均目標價為 400.85 美元。</p>
<ul>
<li>防禦性投資：3 家支付股息的公司報告強勁的第三季度收益</li>
</ul>
<p><strong>查看我們對 Elevance Health 的最新分析</strong></p>
<h2>Elevance Health 價格表現</h2>
<p>NYSE ELV 的股票在週三開盤價為 368.27 美元。Elevance Health, Inc. 的 1 年低點為 273.71 美元，1 年高點為 458.75 美元。該公司的市值為 818.4 億美元，市盈率為 15.05，市盈率/增長比率為 1.93，貝塔係數為 0.51。該公司的債務與股本比率為 0.71，流動比率為 1.56，速動比率為 1.56。該公司的 50 日移動平均價格為 346.57 美元，200 日移動平均價格為 328.18 美元。</p>
<ul>
<li>為什麼 Centene 股票下跌了 40% — 現在是否值得買入</li>
</ul>
<p>Elevance Health (NYSE:ELV - 獲取免費報告) 最近在 10 月 21 日發佈了季度收益數據。該公司報告本季度每股收益為 6.03 美元，超出分析師一致預期的 5.03 美元，超出 1.00 美元。該公司的季度收入為 500.9 億美元，而分析師預期為 492.6 億美元。Elevance Health 的淨利潤率為 2.84%，股本回報率為 16.17%。該公司的季度收入較去年同期增長了 12.0%。去年同期，該公司每股收益為 8.37 美元。研究分析師預計 Elevance Health, Inc. 本年度將發佈 33.96 美元的每股收益。</p>
<h2>Elevance Health 簡介</h2>
<p>(免費報告)</p>
<p>Elevance Health, Inc NYSE: ELV 是一家總部位於美國的大型健康福利公司，提供廣泛的健康保險產品和相關服務。公司總部位於印第安納波利斯，2022 年從 Anthem, Inc 更名為 Elevance Health，同時繼續以既有的州和國家品牌運營面向消費者的健康計劃。Gail Boudreaux 擔任首席執行官和總裁，領導公司在綜合醫療和福利交付方面的戰略重點。</p>
<p>Elevance 的核心業務包括為個人、僱主和政府項目（包括 Medicare 和 Medicaid 管理醫療產品）提供醫療和專業健康計劃。</p>
<h2>精選文章</h2>
<ul>
<li>五隻我們更看好的股票，勝過 Elevance Health</li>
<li>Elon 正在將 SpaceX 上市！$100 的 IPO 前機會！</li>
<li>家族信託如何幫助保護您的財富</li>
<li>請勿刪除，立即閲讀</li>
<li>美國 “出生權” 索賠價值數萬億 - 靜悄悄地激活</li>
<li>執行命令 14330：特朗普迄今為止最大的一次</li>
</ul>
<p><strong>想看看其他對沖基金持有的 ELV 嗎？</strong> 訪問 HoldingsChannel.com 獲取 Elevance Health, Inc. (NYSE:ELV - 免費報告) 的最新 13F 文件和內部交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUVMVg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUVMVg"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
<h2>您現在應該投資 1,000 美元在 Elevance Health 嗎？</h2>
<p>在您考慮 Elevance Health 之前，您需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及他們推薦給客户的股票。MarketBeat 已經識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Elevance Health 並不在名單上。</p>
<p>雖然 Elevance Health 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

醫療業 ETF - SPDR

美國醫療保健供應商 ETF - iShares

醫療業 ETF - Vanguard

<p>Vest Financial LLC 在第三季度減少了對 Elevance Health, Inc. (NYSE:ELV) 的持股，減幅為 10.8%，目前持有 88,982 股，出售了 10,817 股。這些持股的價值約為 2875 萬美元。其他機構投資者也調整了他們的頭寸，其中 Joel Isaacson & Co. LLC 和 Sage Mountain Advisors LLC 的增持尤為顯著。分析師對 Elevance Health 維持 “適度買入” 的評級，平均目標價為 400.85 美元。該股票開盤價為 368.27 美元，市值為 818.4 億美元，市盈率為 15.05</p>

<p>Vest Financial LLC lowered its holdings in Elevance Health, Inc. (NYSE:ELV - Free Report) by 10.8% in the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 88,982 shares of the company's stock after selling 10,817 shares during the period. Vest Financial LLC's holdings in Elevance Health were worth $28,752,000 at the end of the most recent reporting period.</p>
<div class="lb-trans"><p>Vest Financial LLC 在最近向美國證券交易委員會提交的 13F 表格中表示，其在 Elevance Health, Inc. (NYSE:ELV - 免費報告) 的持股在第三季度減少了 10.8%。該基金在此期間出售了 10,817 股後，持有該公司 88,982 股股票。Vest Financial LLC 在 Elevance Health 的持股在最近的報告期末價值為 28,752,000 美元。</p>
</div><ul>
<li>This ETF Is Proof That the Healthcare Rebound Is Real</li>
</ul>
<div class="lb-trans"><ul>
<li>這個 ETF 證明了醫療保健反彈是真實的</li>
</ul>
</div><p>Several other hedge funds and other institutional investors also recently bought and sold shares of the business. Joel Isaacson &amp; Co. LLC boosted its stake in shares of Elevance Health by 45.3% during the 3rd quarter. Joel Isaacson &amp; Co. LLC now owns 1,765 shares of the company's stock valued at $570,000 after buying an additional 550 shares during the last quarter. Sage Mountain Advisors LLC raised its holdings in Elevance Health by 18.2% in the third quarter. Sage Mountain Advisors LLC now owns 1,848 shares of the company's stock valued at $597,000 after acquiring an additional 285 shares in the last quarter. Jackson Thornton Wealth Management LLC bought a new position in Elevance Health during the 3rd quarter valued at $256,000. Americana Partners LLC acquired a new position in Elevance Health during the 3rd quarter worth $393,000. Finally, Professional Advisory Services Inc. increased its position in shares of Elevance Health by 1.6% in the 3rd quarter. Professional Advisory Services Inc. now owns 76,354 shares of the company's stock worth $24,672,000 after purchasing an additional 1,170 shares during the last quarter. 89.24% of the stock is currently owned by hedge funds and other institutional investors.</p>
<div class="lb-trans"><p>其他幾家對沖基金和機構投資者最近也買賣了該公司的股票。Joel Isaacson &amp; Co. LLC 在第三季度將其在 Elevance Health 的股份增加了 45.3%。Joel Isaacson &amp; Co. LLC 現在擁有 1,765 股該公司的股票，價值 570,000 美元，此前在上個季度又購買了 550 股。Sage Mountain Advisors LLC 在第三季度將其在 Elevance Health 的持股增加了 18.2%。Sage Mountain Advisors LLC 現在擁有 1,848 股該公司的股票，價值 597,000 美元，此前在上個季度又收購了 285 股。Jackson Thornton Wealth Management LLC 在第三季度購買了 Elevance Health 的新頭寸，價值 256,000 美元。Americana Partners LLC 在第三季度獲得了 Elevance Health 的新頭寸，價值 393,000 美元。最後，Professional Advisory Services Inc. 在第三季度將其在 Elevance Health 的股份增加了 1.6%。Professional Advisory Services Inc. 現在擁有 76,354 股該公司的股票，價值 24,672,000 美元，此前在上個季度又購買了 1,170 股。目前，89.24% 的股票由對沖基金和其他機構投資者持有。</p>
</div><p>Get <strong>Elevance Health</strong> alerts:</p>
<div class="lb-trans"><p>獲取 <strong>Elevance Health</strong> 的提醒：</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>華爾街分析師預測增長</h2>
</div><p>Several equities analysts have recently commented on the stock. Sanford C. Bernstein reaffirmed an &#34;outperform&#34; rating and set a $431.00 price target on shares of Elevance Health in a research report on Tuesday, January 6th. Robert W. Baird increased their target price on Elevance Health from $297.00 to $340.00 and gave the stock a &#34;neutral&#34; rating in a report on Thursday, December 11th. Mizuho set a $413.00 price target on Elevance Health in a report on Friday, January 9th. Bank of America upped their price target on Elevance Health from $330.00 to $370.00 and gave the company a &#34;neutral&#34; rating in a research report on Friday, October 10th. Finally, Wells Fargo &amp; Company lifted their price objective on shares of Elevance Health from $403.00 to $424.00 and gave the stock an &#34;overweight&#34; rating in a report on Wednesday, January 7th. Thirteen analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of &#34;Moderate Buy&#34; and an average target price of $400.85.</p>
<div class="lb-trans"><p>幾位股票分析師最近對該股票發表了評論。Sanford C. Bernstein 在 1 月 6 日的研究報告中重申了 “跑贏大盤” 的評級，並設定了 Elevance Health 股票的目標價為 431.00 美元。Robert W. Baird 將 Elevance Health 的目標價從 297.00 美元上調至 340.00 美元，並在 12 月 11 日的報告中給予該股票 “中性” 評級。Mizuho 在 1 月 9 日的報告中設定了 Elevance Health 的目標價為 413.00 美元。美國銀行在 10 月 10 日的研究報告中將 Elevance Health 的目標價從 330.00 美元上調至 370.00 美元，並給予該公司 “中性” 評級。最後，富國銀行在 1 月 7 日的報告中將 Elevance Health 股票的目標價從 403.00 美元上調至 424.00 美元，並給予該股票 “超配” 評級。十三位分析師對該股票給予了買入評級，十二位分析師對該公司的股票給予了持有評級。根據 MarketBeat 的數據，該公司目前的平均評級為 “適度買入”，平均目標價為 400.85 美元。</p>
</div><ul>
<li>Getting Defensive: 3 Dividend Payers Reporting Strong Q3 Earnings</li>
</ul>
<div class="lb-trans"><ul>
<li>防禦性投資：3 家支付股息的公司報告強勁的第三季度收益</li>
</ul>
</div><p><strong>View Our Latest Analysis on Elevance Health</strong></p>
<div class="lb-trans"><p><strong>查看我們對 Elevance Health 的最新分析</strong></p>
</div><h2>Elevance Health Price Performance</h2>
<div class="lb-trans"><h2>Elevance Health 價格表現</h2>
</div><p>Shares of NYSE ELV opened at $368.27 on Wednesday. Elevance Health, Inc. has a 1-year low of $273.71 and a 1-year high of $458.75. The firm has a market capitalization of $81.84 billion, a PE ratio of 15.05, a P/E/G ratio of 1.93 and a beta of 0.51. The company has a debt-to-equity ratio of 0.71, a current ratio of 1.56 and a quick ratio of 1.56. The business's fifty day moving average price is $346.57 and its two-hundred day moving average price is $328.18.</p>
<div class="lb-trans"><p>NYSE ELV 的股票在週三開盤價為 368.27 美元。Elevance Health, Inc. 的 1 年低點為 273.71 美元，1 年高點為 458.75 美元。該公司的市值為 818.4 億美元，市盈率為 15.05，市盈率/增長比率為 1.93，貝塔係數為 0.51。該公司的債務與股本比率為 0.71，流動比率為 1.56，速動比率為 1.56。該公司的 50 日移動平均價格為 346.57 美元，200 日移動平均價格為 328.18 美元。</p>
</div><ul>
<li>Why Centene Stock Dropped 40% — And Whether It's a Buy Now</li>
</ul>
<div class="lb-trans"><ul>
<li>為什麼 Centene 股票下跌了 40% — 現在是否值得買入</li>
</ul>
</div><p>Elevance Health (NYSE:ELV - Get Free Report) last released its quarterly earnings data on Tuesday, October 21st. The company reported $6.03 earnings per share for the quarter, topping analysts' consensus estimates of $5.03 by $1.00. The business had revenue of $50.09 billion for the quarter, compared to analysts' expectations of $49.26 billion. Elevance Health had a net margin of 2.84% and a return on equity of 16.17%. The company's revenue for the quarter was up 12.0% compared to the same quarter last year. During the same quarter last year, the company earned $8.37 EPS. On average, research analysts expect that Elevance Health, Inc. will post 33.96 EPS for the current year.</p>
<div class="lb-trans"><p>Elevance Health (NYSE:ELV - 獲取免費報告) 最近在 10 月 21 日發佈了季度收益數據。該公司報告本季度每股收益為 6.03 美元，超出分析師一致預期的 5.03 美元，超出 1.00 美元。該公司的季度收入為 500.9 億美元，而分析師預期為 492.6 億美元。Elevance Health 的淨利潤率為 2.84%，股本回報率為 16.17%。該公司的季度收入較去年同期增長了 12.0%。去年同期，該公司每股收益為 8.37 美元。研究分析師預計 Elevance Health, Inc. 本年度將發佈 33.96 美元的每股收益。</p>
</div><h2>Elevance Health Profile</h2>
<div class="lb-trans"><h2>Elevance Health 簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>(免費報告)</p>
</div><p>Elevance Health, Inc NYSE: ELV is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company's strategic focus on integrated health care and benefit delivery.</p>
<div class="lb-trans"><p>Elevance Health, Inc NYSE: ELV 是一家總部位於美國的大型健康福利公司，提供廣泛的健康保險產品和相關服務。公司總部位於印第安納波利斯，2022 年從 Anthem, Inc 更名為 Elevance Health，同時繼續以既有的州和國家品牌運營面向消費者的健康計劃。Gail Boudreaux 擔任首席執行官和總裁，領導公司在綜合醫療和福利交付方面的戰略重點。</p>
</div><p>Elevance's core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.</p>
<div class="lb-trans"><p>Elevance 的核心業務包括為個人、僱主和政府項目（包括 Medicare 和 Medicaid 管理醫療產品）提供醫療和專業健康計劃。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精選文章</h2>
</div><ul>
<li>Five stocks we like better than Elevance Health</li>
<li>Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!</li>
<li>How a Family Trust May Be Able To Help Preserve Your Wealth</li>
<li>Do not delete, read immediately</li>
<li>A U.S. “birthright” claim worth trillions - activated quietly</li>
<li>Executive Order 14330: Trump’s Biggest Yet</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 Elevance Health</li>
<li>Elon 正在將 SpaceX 上市！$100 的 IPO 前機會！</li>
<li>家族信託如何幫助保護您的財富</li>
<li>請勿刪除，立即閲讀</li>
<li>美國 “出生權” 索賠價值數萬億 - 靜悄悄地激活</li>
<li>執行命令 14330：特朗普迄今為止最大的一次</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding ELV?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Elevance Health, Inc. (NYSE:ELV - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他對沖基金持有的 ELV 嗎？</strong> 訪問 HoldingsChannel.com 獲取 Elevance Health, Inc. (NYSE:ELV - 免費報告) 的最新 13F 文件和內部交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUVMVg" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=ELV"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Elevance Health Right Now?</h2>
<div class="lb-trans"><h2>您現在應該投資 1,000 美元在 Elevance Health 嗎？</h2>
</div><p>Before you consider Elevance Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在您考慮 Elevance Health 之前，您需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Elevance Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及他們推薦給客户的股票。MarketBeat 已經識別出五隻頂級分析師悄悄向客户推薦的股票，建議在更廣泛的市場注意到之前購買……而 Elevance Health 並不在名單上。</p>
</div><p>While Elevance Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Elevance Health 目前在分析師中獲得了中等買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Vest Financial LLC 減少了其在 Elevance Health, Inc. $ELV 的持倉